Federal Register / Vol. 85, No. 230 / Monday, November 30, 2020 / Notices 76589 

TABLE 1—FEDERAL MEDICAL ASSISTANCE PERCENTAGES AND ENHANCED FEDERAL MEDICAL ASSISTANCE PERCENTAGES, 

EFFECTIVE OCTOBER 1, 2021–SEPTEMBER 30, 2022—Continued 

[Fiscal year 2022] 

State 

Federal Medical 

Assistance 

Percentages 

Enhanced Federal 

Medical Assistance 

Percentages 

Texas ....................................................................................................................................... 60.80 72.56 

Utah ......................................................................................................................................... 66.83 76.78 

Vermont ................................................................................................................................... 56.47 69.53 

Virgin Islands * ......................................................................................................................... 55.00 68.50 

Virginia ..................................................................................................................................... 50.00 65.00 

Washington .............................................................................................................................. 50.00 65.00 

West Virginia ............................................................................................................................ 74.68 82.28 

Wisconsin ................................................................................................................................. 59.88 71.92 

Wyoming .................................................................................................................................. 50.00 65.00 

* For purposes of section 1118 of the Social Security Act, the percentage used under titles I, X, XIV, and XVI will be 75 per centum for the territories. 

** For purposes of section 1905(b) of the Social Security Act, the FMAP for the District of Columbia, for purposes of titles XIX and XXI, shall be 

70 percent. The values for the District of Columbia in the table were set for the state plan under titles XIX and XXI and for capitation payments 

and disproportionate share hospital (DSH) allotments under those titles. For other purposes, the percentage for DC is 50.00, unless otherwise 

specified by law. 

[FR Doc. 2020–26387 Filed 11–27–20; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

December 10, 2020, 09:30 a.m. to 

December 10, 2020, 05:00 p.m., National 

Institutes of Health, Eunice Kennedy 

Shriver National Institute of, 6701B 

Rockledge Drive, Bethesda, MD 20892, 

which was published in the Federal 

Register on November 16, 2020, 85 FR 

73063. 

This notice is being amended to 

change the meeting start time from 

10:00 a.m. to 9:30 a.m. The meeting is 

closed to the public. 

Dated: November 24, 2020. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–26370 Filed 11–27–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Mechanism for Time-Sensitive Drug Abuse 

Research (R21 Clinical Trial Optional). 

Date: December 9, 2020. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Sheila Pirooznia, Ph.D., 

Scientific Review Officer, Division of 

Extramural Review, Scientific Review 

Branch, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 496–9350, 

sheila.pirooznia@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: November 24, 2020. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–26367 Filed 11–27–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Spine and Vertebral Disc. 

Date: December 17, 2020. 

Time: 11:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Aftab A. Ansari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 


TKELLEY on DSKBCP9HB2PROD with NOTICES